Search results
AMPH- A Generic Drugmaker Looking to Expand Via Acquisition, Biosimilars Moves
MoneyShow via Yahoo Finance· 3 days agoAmphastar Pharmaceuticals Inc. (AMPH) is a generic drug company founded in 1996 that went public in 2014. Amphastar focuses on drugs ...
A cheap drug may slow down aging. A study will determine if it works
NPR· 5 days agoBut Dr. Barzilai says it's been slow going to get it funded. "The main obstacle with funding this...
Analyst Report: West Pharmaceutical Services, Inc.
Morningstar Research via Yahoo Finance· 8 hours agoWest sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company</ ...
Weight loss drugs like Wegovy have taken the country by storm. But who can afford them?
USA TODAY· 1 day agoDrugmakers say they price drugs to recoup years of research and development costs. They often also...
Americans could get one-time payment from $85 million generic drug settlement
The US Sun· 4 days agoDetails noted in the suit accused the two manufacturers and their affiliates of working in tandem to...
Mark Cuban has a simple question for CVS’s drug middleman: Why don’t you publish your prices?
Ohio Capital Journal via Yahoo News· 14 hours agoBusinessman and TV personality Mark Cuban has a seemingly straightforward question for the huge drug...
Bristol Myers to cut 6% of workforce, trim drug pipeline
BioPharma Dive via Yahoo Finance· 2 days agoThe company has discontinued 12 programs, including a successor version of its immunotherapy Yervoy,...
White House Plan To Curb Drug Shortages Doesn’t Address Generics’ Quality
Forbes· 3 days agoDrug shortages are at an all-time high. The White House rolled out a plan earlier this month...
AbbVie (ABBV) Beats on Q1 Earnings & Sales, Ups '24 EPS View
Zacks via Yahoo Finance· 7 hours agoAbbVie shares international profits earned from Imbruvica with J&J. The company’s share of profit...
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
Zacks via Yahoo Finance· 1 day agoThe stock has risen 2.9% in the past year. Merck: Its key cancerdrug Keytruda and HPV vaccine...
